CASE REPORT article
Front. Cardiovasc. Med.
Sec. Lipids in Cardiovascular Disease
Intensive Lipid-Lowering Therapy–Related Regression of a Vulnerable Plaque Confirmed by Serial Optical Coherence Tomography: A Case Report
Junru Qu 1
Kun Liu 1
Neil Johnson 1
Kenji Wagatsuma 2
Yingying Su 3
Beibei Du 1
Yuquan He 1
1. China-Japan Union Hospital of Jilin University, Changchun, China
2. Tsukuba Memorial Hospital, Tsukuba, Japan
3. Changchun University of Chinese Medicine, Changchun, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Abstract
Introduction: Acute coronary syndrome (ACS) remains a leading cause of mortality and disability worldwide. Vulnerable plaques constitute a key pathological substrate underlying ACS. Although lipid-lowering therapy (LLT) is central to plaque stabilization and secondary prevention in ACS, a substantial proportion of patients fail to achieve recommended lipid targets, underscoring a persistent gap between guideline recommendations and real-world outcomes. Accordingly, serial assessment of plaque morphology using high-resolution intracoronary imaging may provide clinically actionable guidance for individualized management. Here, we report a case in which a ruptured coronary plaque in a patient with acute myocardial infarction (AMI) underwent progressive healing, remaining phenotypically vulnerable at early follow-up before ultimately evolving into a stable plaque under intensive lipid-lowering and dual antiplatelet therapy, as documented by serial optical coherence tomography (OCT). Case presentation: A 52-year-old patient presented with acute chest pain and was diagnosed with ST-segment elevation myocardial infarction (STEMI). After coronary angiography (CAG) and thrombus aspiration restored coronary flow, OCT evaluation was performed, and a deferred stenting strategy combined with intensive lipid-lowering therapy and dual antiplatelet therapy was adopted. At the 1-month follow-up, repeat CAG and OCT supported continued conservative management, and stent implantation was not performed. Over the subsequent year, the patient achieved sustained lipid control under close follow-up, without recurrent chest pain or other cardiac-related symptoms, and conservative management was continued without stent implantation. Serial OCT at one month and one year demonstrated a stepwise morphological transition of the culprit lesion, from an initially ruptured plaque to a healed but still vulnerable phenotype at early follow-up, and ultimately to a stable plaque phenotype at one year. Conclusion: Vulnerable plaques represent a principal pathological driver of acute coronary events. Sustained and effective LLT promotes plaque stabilization and regression, while serial OCT, owing to its high resolution and reproducibility, enables dynamic assessment of plaque morphology and supports individualized management in patients with ACS.
Summary
Keywords
acute coronary syndrome1, Case report5, Inclisiran3, lipid-lowering therapy4, Vulnerable Plaque2
Received
01 September 2025
Accepted
02 February 2026
Copyright
© 2026 Qu, Liu, Johnson, Wagatsuma, Su, Du and He. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Beibei Du
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.